The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Introduces a New Reproductive Health Guideline

The ACR Introduces a New Reproductive Health Guideline

March 12, 2020 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Honchar Roman / shutterstock.com

Honchar Roman / shutterstock.com

Reproductive health can be a concern for patients with rheumatic diseases, and practitioners in both rheumatology and obstetrics/gynecology often work closely together. The 2020 ACR Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases, new clinical recommendations developed by an ACR-convened group for pregnant women, post-menopausal women, lactating women, and women and men trying to conceive or delay conception, was published online in Arthritis & Rheumatology and Arthritis Care & Research Feb. 24.1

You Might Also Like
  • The ACR Introduces New Reproductive Health Guideline
  • The ACR Has Introduced a New Reproductive Health Guideline Draft
  • 2015 ACR Guideline for the Treatment of Rheumatoid Arthritis Now Available
Explore This Issue
March 2020
Also By This Author
  • 2014 ACR/ARHP Annual Meeting: Alive and Growing

The evidence-based guideline includes contraceptive recommendations and suggestions for rheumatologists co-managing patients with obstetrician-gynecologists (OB/GYNs) and other specialists.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Methodology

The guideline’s literature review team accepted 319 out of 11,760 published manuscripts for systematic review, said Eliza Chakravarty, MD, MS, associate member, Arthritis and Clinical Immunology Research Program at the Oklahoma Medical Research Foundation, Oklahoma City. Other fields have many well-structured, randomized, controlled trials, but “we wound up working with relatively lower-quality evidence based on the available studies,” she said. Thus, most of the recommendations are conditional, not strong.

The Voting Panel included rheumatologists, OB/GYNs, reproductive medicine specialists and patients. The panel required 70% agreement to reach consensus on whether to include or discard recommendations. The guideline also includes good practice statements, which are clinical suggestions, such as counseling rheumatic and musculoskeletal disease (RMD) patients on the use of potentially teratogenic medications.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Principal Investigator Lisa R. Sammaritano, MD, associate professor of clinical medicine at Weill Cornell Medicine and associate attending physician at the Hospital for Special Surgery, New York, reviewed the final recommendations, the result of a three-year effort with input from medical professionals and patients. Patients on the panel had a consistent message, she said: “My rheumatologist knows me much better than my gynecologist.” Even if you are pressed for time, “patients really do want to talk to their rheumatologists about these topics,” she said.

Dr. Sammaritano‘Our patients really do want to talk to their rheumatologists about these topics.’  —Dr. Sammaritano

Contraception

Condoms and the estrogen-progestin combination pill have lower efficacy in preventing pregnancy, so the guideline suggests the more effective long-acting reversible contraception (LARC) methods, such as intrauterine devices or implants, when possible.2

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Good practice statements on contraception: Discuss contraception and pregnancy plans at an initial or early office visit or when initiating treatment with potentially teratogenic medications, and counsel patients on contraceptive methods based on efficacy, safety and personal values.

Recommendations include:

  • Encourage the use of effective LARC for all patients;
  • Avoid estrogen in antiphospholipid antibody (aPL) positive patients or those with active systemic lupus erythematosus (SLE), using an intra-uterine device or the less-effective progestin-only pill in these patients;
  • Avoid depot medroxyprogesterone acetate injections in patients at high risk for osteoporosis; and
  • Encourage all patients to use over-the-counter morning-after emergency contraception, if desired.

Fertility/Assisted Reproductive Technology (ART)

Fertility is becoming more of a concern for patients, because women may delay pregnancy until their disease is inactive, said Dr. Sammaritano. “As a result, they may end up needing fertility therapy. Oocyte or embryo cryopreservation is now standard care, rather than experimental, and if you haven’t yet had patients ask you about this, I guarantee that you will.”

Elevated estrogen levels during ovarian stimulation and retrieval mean flare and/or thrombosis are major concerns for women with SLE. Coordinate care with a patient’s reproductive endocrinologist in these cases, the Voting Panel suggested.

Recommendations include:

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Guidelines Tagged With: contraceptive, pregnancy, reproductive healthIssue: March 2020

You Might Also Like:
  • The ACR Introduces New Reproductive Health Guideline
  • The ACR Has Introduced a New Reproductive Health Guideline Draft
  • 2015 ACR Guideline for the Treatment of Rheumatoid Arthritis Now Available
  • Collaborative Guideline Addresses the Perioperative Use of Antirheumatic Drug Therapy

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.